• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中央病理学审查及其在上尿路尿路上皮癌患者中的预后价值:一项全国多机构研究。

Central pathology review and its prognostic value in upper tract urothelial carcinoma patients: a nationwide multi-institutional study.

机构信息

Department of Urology, Taiwan Adventist Hospital, Taipei, Taiwan.

Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.

出版信息

Sci Rep. 2024 Aug 23;14(1):19633. doi: 10.1038/s41598-024-70785-w.

DOI:10.1038/s41598-024-70785-w
PMID:39179740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11343867/
Abstract

The prognostic value of central pathology review in upper urinary tract cancer (UTUC) remains inadequately addressed in existing literature. In this study, we conducted an extensive central pathology review and presented its influence on multi-center UTUC studies. We conducted a retrospective review of patients who underwent radical nephroureterectomy or segmental resection for UTUC to determine eligibility for central pathology review. In the Taiwan UTUC Collaboration cohort, 377 cases met the criteria for pathology review. We assessed agreement between pathologists using both the total percentage of agreement and simple kappa statistics. The prognostic implications of original and review pathology for various parameters were examined using the Cox regression model. This study included 209 female and 168 male participants. Pathology review revealed substantial interobserver variability in pT staging, with a particularly high rate of pT2 cases being upgraded to pT3 upon central review (17/70 pT2 stage made by local pathologists were finally confirmed as pT3 disease by the review pathologist). The local pathologist cohort identified fewer significant histological predictors in survival models compared to the review pathology cohort. Advanced pT stage, perineural invasion (PNI), and positive surgical margin were independent predictors of poorer overall survival and cancer-specific survival. PNI, lymphatic vascular invasion, and positive surgical margin were independent predictors of disease recurrence. Substantial interobserver variability in histological assessment underscores the importance of centralized pathology review for both multi-center studies and accurate post-operative management of UTUC patients. Advanced stage, perineural invasion, and margin status were significant histological predictors of oncological outcomes.

摘要

中央病理学审查在上尿路尿路上皮癌(UTUC)中的预后价值在现有文献中仍未得到充分解决。在这项研究中,我们进行了广泛的中央病理学审查,并展示了其对多中心 UTUC 研究的影响。我们对接受根治性肾输尿管切除术或节段切除术治疗 UTUC 的患者进行了回顾性审查,以确定是否有资格进行中央病理学审查。在台湾 UTUC 协作队列中,有 377 例符合病理审查标准。我们使用总一致性百分比和简单 kappa 统计来评估病理学家之间的一致性。使用 Cox 回归模型检查原始和审查病理学对各种参数的预后意义。本研究包括 209 名女性和 168 名男性参与者。病理学审查显示 pT 分期存在明显的观察者间变异性,尤其是局部病理学家诊断为 pT2 期的病例中有相当高的比例在中央审查后升级为 pT3 期(70 例局部病理学家诊断为 pT2 期的病例中,有 17 例最终被审查病理学家确认为 pT3 期疾病)。与审查病理学队列相比,局部病理学家队列在生存模型中确定的显著组织学预测因素较少。高级 pT 分期、神经周围侵犯(PNI)和阳性手术切缘是总生存率和癌症特异性生存率较差的独立预测因素。PNI、淋巴血管侵犯和阳性手术切缘是疾病复发的独立预测因素。组织学评估存在明显的观察者间变异性,强调了中央病理学审查对于多中心研究和 UTUC 患者术后管理的重要性。高级别分期、PNI 和切缘状态是肿瘤学结果的重要组织学预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f64c/11343867/e824ada99eea/41598_2024_70785_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f64c/11343867/c5acff4f665a/41598_2024_70785_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f64c/11343867/e824ada99eea/41598_2024_70785_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f64c/11343867/c5acff4f665a/41598_2024_70785_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f64c/11343867/e824ada99eea/41598_2024_70785_Fig2_HTML.jpg

相似文献

1
Central pathology review and its prognostic value in upper tract urothelial carcinoma patients: a nationwide multi-institutional study.中央病理学审查及其在上尿路尿路上皮癌患者中的预后价值:一项全国多机构研究。
Sci Rep. 2024 Aug 23;14(1):19633. doi: 10.1038/s41598-024-70785-w.
2
Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.合并不同组织学类型对上尿路尿路上皮癌患者根治性肾输尿管切除术后预后的影响。
Urol Oncol. 2015 May;33(5):204.e9-16. doi: 10.1016/j.urolonc.2015.02.010. Epub 2015 Mar 20.
3
Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial Carcinoma.浸润性上尿路上皮癌的预后因素和风险分层。
Clin Genitourin Cancer. 2018 Aug;16(4):e751-e760. doi: 10.1016/j.clgc.2018.01.014. Epub 2018 Feb 6.
4
Peripelvic/periureteral fat invasion is independently associated with worse prognosis in pT3 upper tract urothelial carcinoma.肾盂周/输尿管周脂肪浸润与pT3期上尿路尿路上皮癌的预后较差独立相关。
World J Urol. 2014 Feb;32(1):157-63. doi: 10.1007/s00345-013-1073-8. Epub 2013 Apr 9.
5
Perineural Invasion is a Powerful Prognostic Factor for Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy.神经周围侵犯是根治性肾输尿管切除术后上尿路上皮癌的一个强有力的预后因素。
Ann Surg Oncol. 2022 May;29(5):3306-3317. doi: 10.1245/s10434-021-11265-7. Epub 2022 Jan 7.
6
Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.非肌层浸润性膀胱肿瘤史对上尿路尿路上皮癌患者的预后意义。
Urol Oncol. 2013 Nov;31(8):1615-20. doi: 10.1016/j.urolonc.2012.03.004. Epub 2012 Apr 21.
7
Prognostic significance of tumor multifocality on outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy: A cohort study.根治性肾输尿管切除术治疗上尿路上皮癌患者肿瘤多灶性对预后的影响:队列研究。
Curr Probl Cancer. 2021 Dec;45(6):100747. doi: 10.1016/j.currproblcancer.2021.100747. Epub 2021 Apr 15.
8
A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma.一种新型基于风险的方法模拟上尿路上皮癌患者肾输尿管根治性切除术后的肿瘤监测。
Eur Urol Oncol. 2020 Dec;3(6):756-763. doi: 10.1016/j.euo.2019.06.021. Epub 2019 Aug 6.
9
Prevalence and oncologic impact of chronic kidney disease for upper tract urothelial carcinoma in endemic area.流行率和肿瘤学影响的慢性肾病为上尿路尿路上皮癌在流行地区。
J Formos Med Assoc. 2024 Jul;123(7):758-763. doi: 10.1016/j.jfma.2023.11.011. Epub 2023 Dec 2.
10
Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.肾输尿管切除术后顺铂辅助化疗治疗局部晚期上尿路上皮癌的疗效:多机构回顾性研究。
World J Urol. 2017 Oct;35(10):1569-1575. doi: 10.1007/s00345-017-2032-6. Epub 2017 Apr 10.

引用本文的文献

1
Improving Risk Stratification in pT3 Upper Tract Urothelial Carcinoma: A Focus on Invasion Patterns.改善pT3上尿路尿路上皮癌的风险分层:关注浸润模式。
Cancers (Basel). 2025 Mar 8;17(6):923. doi: 10.3390/cancers17060923.

本文引用的文献

1
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南:2023 年更新版。
Eur Urol. 2023 Jul;84(1):49-64. doi: 10.1016/j.eururo.2023.03.013. Epub 2023 Mar 24.
2
Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort Analysis.辅助化疗对上尿路尿路上皮癌组织学变异的影响:一项倾向评分匹配队列分析
Front Oncol. 2022 Apr 22;12:843715. doi: 10.3389/fonc.2022.843715. eCollection 2022.
3
Impact of Pathology Review in Adverse Histological Characteristics and pT Stages of Upper Tract Urothelial Cancer in a Multicenter Study.
多中心研究中病理复查对上尿路尿路上皮癌不良组织学特征及pT分期的影响
Front Oncol. 2021 Nov 25;11:757359. doi: 10.3389/fonc.2021.757359. eCollection 2021.
4
Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter-Nephroureterectomy and Ureterectomy Specimens: Recommendations From the International Collaboration on Cancer Reporting (ICCR).国际癌症报告合作组织(ICCR)关于肾盂和输尿管肾输尿管切除术及输尿管切除术标本中癌报告的数据集:建议。
Am J Surg Pathol. 2019 Oct;43(10):e1-e12. doi: 10.1097/PAS.0000000000001305.
5
Second Opinion Expert Pathology Review in Bladder Cancer: Implications for Patient Care.膀胱癌的二次专家病理评估:对患者护理的影响
Int J Surg Pathol. 2018 Feb;26(1):12-17. doi: 10.1177/1066896917730903. Epub 2017 Sep 14.
6
Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital.在社区实践中,尿路上皮癌的变异(分化)组织学分化认识不足:在大型转诊医院进行强制性中心病理检查的影响。
Urol Oncol. 2013 Nov;31(8):1650-5. doi: 10.1016/j.urolonc.2012.04.009. Epub 2012 May 17.
7
The role of pathology review of transurethral bladder tumor resection specimens in the modern era.经尿道膀胱肿瘤切除术标本的病理复查在现代的作用。
J Urol. 2010 Mar;183(3):921-7. doi: 10.1016/j.juro.2009.11.049. Epub 2010 Jan 20.
8
Central pathology review in multicenter trials and studies: lessons from the nephroblastoma trials.
Cancer. 2009 May 1;115(9):1977-83. doi: 10.1002/cncr.24214.
9
Review pathology in a diagnostic bladder cancer trial: effect of patient risk category.
Urology. 2006 Apr;67(4):751-5. doi: 10.1016/j.urology.2005.10.028. Epub 2006 Mar 29.
10
The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer Trials.
J Urol. 2000 Nov;164(5):1533-7. doi: 10.1097/00005392-200011000-00017.